Gregorio Iraola is co-founder and CEO of Kinzbio, a biotech startup in Uruguay developing preventives and therapeutics for antibiotic-resistant bacteria using an innovative technology platform based on the biology of jumbo phages. He is an International Fellow at the Wellcome Sanger Institute (UK) and Adjunct International Professor at the Universidad Mayor (Chile). His research focuses on understanding and combating bacterial infections and AMR from a one-health perspective, integrating the human microbiome with its surroundings.
Gregorio completed his bachelor’s degree in biology and went on to complete his master’s degree in bioinformatics and PhD in computational microbiology at Institut Pasteur Montevideo, Uruguay.